BIIB — BiogenFREE
Median target
$238.5
across the calls below
Implied return
-4.2%
median target vs. price
Coverage
33 analysts · 48 calls
within the date window
Consensus
19/12/2+17 net
Buy / Hold / Sell
Current analyst calls on BIIB
Each row is one analyst's live rating and price target. Sorted by implied return by default — click any column header to re-sort. By default only calls updated in the last 12 months are shown — change or clear the bound to see all.
48 of 64 calls shown
| Alexandria Hammond | – | – | – | Wolfe Research | Buy | $300 | +20.5% | Aug 13, 2026 | |
| Michael Yee | – | – | – | UBS | Buy | $270 | +8.5% | Oct 9, 2026 | |
| Brian Abrahams | – | – | – | RBC Capital | Buy | $260 | +4.5% | Aug 25, 2026 | |
| Yatin Suneja | – | – | – | Guggenheim | Buy | $260 | +4.5% | Apr 30, 2026 | |
| Ami Fadia | – | – | – | Needham | Buy | $256 | +2.8% | Jun 29, 2026 | |
| Ami Fadia | – | – | – | Needham | Buy | $256 | +2.8% | Oct 6, 2026 | |
| Brian Abrahams | – | – | – | RBC Capital | Buy | $256 | +2.8% | Oct 8, 2026 | |
| Andrew Tsai | – | – | – | Jefferies | Buy | $255 | +2.4% | Jul 30, 2026 | |
| Andrew Tsai | – | – | – | Jefferies | Buy | $255 | +2.4% | Oct 5, 2026 | |
| Andrew Fein | – | – | – | H.C. Wainwright | Buy | $251 | +0.8% | Jul 30, 2026 | |
| Mohit Bansal | – | – | – | Wells Fargo | Buy | $250 | +0.4% | Sep 18, 2026 | |
| Salveen Richter | – | – | – | Goldman Sachs | Buy | $250 | +0.4% | Jul 13, 2026 | |
| Salveen Richter | – | – | – | Goldman Sachs | Buy | $250 | +0.4% | May 15, 2026 | |
| Sumant Kulkarni | – | – | – | Canaccord Genuity | Buy | $248 | -0.4% | Jul 30, 2026 | |
| David Amsellem | – | – | – | Piper Sandler | Buy | $245 | -1.6% | Oct 5, 2026 | |
| David Amsellem | – | – | – | Piper Sandler | Buy | $245 | -1.6% | Sep 3, 2026 | |
| Ilya Zubkov | – | – | – | Freedom Capital Markets | Buy | $245 | -1.6% | May 1, 2026 | |
| Sumant Kulkarni | – | – | – | Canaccord Genuity | Buy | $245 | -1.6% | Jul 15, 2026 | |
| Paul Matteis | – | – | – | Stifel Nicolaus | Buy | $242 | -2.8% | Aug 2, 2026 | |
| Salim Syed | – | – | – | Mizuho Securities | Buy | $241 | -3.2% | Aug 3, 2026 | |
| Michael Yee | – | – | – | UBS | Buy | $240 | -3.6% | Jul 30, 2026 | |
| Andrew Fein | – | – | – | H.C. Wainwright | Buy | $237 | -4.8% | Jul 14, 2026 | |
| Eve Burstein | – | – | – | Bernstein | Buy | $236 | -5.2% | Sep 25, 2026 | |
| Danielle Brill | – | – | – | Truist Financial | Buy | $235 | -5.6% | Jul 13, 2026 | |
| Phil Nadeau | – | – | – | TD Cowen | Buy | $225 | -9.6% | Jul 30, 2026 | |
| Terence Flynn | – | – | – | Morgan Stanley | Hold | $222 | -10.8% | Jul 8, 2026 | |
| Terence Flynn | – | – | – | Morgan Stanley | Hold | $222 | -10.8% | Jul 14, 2026 | |
| Jason Zemansky | – | – | – | Bank of America Securities | Hold | $219 | -12.0% | Jul 29, 2026 | |
| Jason Zemansky | – | – | – | Bank of America Securities | Hold | $217 | -12.8% | Jul 14, 2026 | |
| Geoff Meacham | – | – | – | Citi | Hold | $215 | -13.6% | Aug 3, 2026 | |
| Laura Chico | – | – | – | Wedbush | Hold | $215 | -13.6% | Jul 31, 2026 | |
| Phil Nadeau | – | – | – | TD Cowen | Buy | $215 | -13.6% | Jul 14, 2026 | |
| Chris Schott | – | – | – | J.P. Morgan | Hold | $210 | -15.6% | Jul 30, 2026 | |
| Matthew Harrison | – | – | – | Morgan Stanley | Hold | $206 | -17.3% | Apr 30, 2026 | |
| Laura Chico | – | – | – | Wedbush | Hold | $201 | -19.3% | Jul 13, 2026 | |
| Emily Field | – | – | – | Barclays | Hold | $200 | -19.7% | Aug 12, 2026 | |
| Evan Seigerman | – | – | – | BMO Capital | Hold | $196 | -21.3% | Jul 15, 2026 | |
| Evan Seigerman | – | – | – | BMO Capital | Hold | $196 | -21.3% | May 14, 2026 | |
| Srikripa Devarakonda | – | – | – | Truist Financial | Hold | $189 | -24.1% | Apr 13, 2026 | |
| Morten Herholdt | – | – | – | HSBC | Sell | $175 | -29.7% | Sep 10, 2026 | |
| Rajesh Kumar | – | – | – | HSBC | Sell | $150 | -39.7% | Mar 17, 2026 | |
| Danielle Brill | – | – | – | Truist Financial | Hold | – | – | May 15, 2026 | |
| Jasper Hellweg | – | – | – | Argus Research | Hold | – | – | Jul 10, 2026 | |
| Jay Olson | – | – | – | Oppenheimer | Hold | – | – | Aug 17, 2026 | |
| Myles Minter | – | – | – | William Blair | Buy | – | – | Jul 14, 2026 | |
| Myles Minter | – | – | – | William Blair | Buy | – | – | May 22, 2026 | |
| Thomas Shrader | – | – | – | BTIG | Hold | – | – | Jul 13, 2026 | |
| Umer Raffat | – | – | – | Evercore ISI | Buy | – | – | May 15, 2026 |
Analyst track records are Premium — unlock every analyst's score, rank and success rate.
Implied return is the move the stock would make if the analyst's target were hit. These are forward-looking predictions, not realized returns. Only reliable-basis calls are included; the consensus figures above are computed from the calls in this table.
BIIB elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-09-24 | Congress | Maria Elvira SalazarFL-FL27 | Sale | since trade +10.0%, vs market -11.6% | $1K–$15K |
| 2026-08-18 | Congress | Kevin HernOK-OK01 | Sale | since trade +17.1%, vs market -18.8% | $1K–$15K |
| 2026-06-05 | Congress | Gilbert CisnerosCA-CA39 | Purchase | since trade +27.4%, vs market +24.9% | $1K–$15K |
| 2026-06-02 | Congress | Maria Elvira SalazarFL-FL27 | Sale | since trade +31.8%, vs market -32.3% | $15K–$50K |
| 2026-05-12 | Congress | Maria Elvira SalazarFL-FL27 | Purchase | since trade +24.9%, vs market +22.4% | $1K–$15K |
| 2026-05-11 | Congress | Maria Elvira SalazarFL-FL27 | Purchase | since trade +25.8%, vs market +23.5% | $1K–$15K |
| 2026-05-11 | Congress | Maria Elvira SalazarFL-FL27 | Purchase | since trade +25.8%, vs market +23.5% | $50K–$100K |
| 2026-01-30 | Congress | Gilbert CisnerosCA-CA39 | Purchase | since trade +38.4%, vs market +29.1% | $1K–$15K |
| 2025-12-12 | Executive | Trump, Donald JPresident | Purchase | BIOGEN INC | $1,001 - $15,000 |
| 2025-11-14 | Executive | Trump, Donald JPresident | Transaction | BIOGEN INC | $1,001 - $15,000 |
More: congressional trades on BIIB · insider activity · executive branch · trending